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Kayaba, Yuji, Akira Nakamura, Yoshitoshi Kasuya,
Takashi Ohuchi, Masashi Yanagisawa, Issei Komuro,
Yasuichiro Fukuda, and Tomoyuki Kuwaki. Attenuated
defense response and low basal blood pressure in orexin
knockout mice. Am J Physiol Regul Integr Comp Physiol 285:
R581–R593, 2003. First published May 15, 2003; 10.1152/
ajpregu.00671.2002.—The perifornical area of the hypothal-
amus has been known as the center for the defense response,
or “fight or flight” response, which is characterized by a
concomitant rise in arterial blood pressure (AP), heart rate
(HR), and respiratory frequency (Rf). We examined whether
orexin, a recently identified hypothalamic neuropeptide, con-
tributes to the defense response and basal cardiovascular
regulation using orexin knockout mice. Microinjection of a
GABA-A receptor antagonist, bicuculline methiodide (0.1–1
mM in 20 nl), to the perifornical area in urethane-anesthe-
tized wild-type mice elicited dose-dependent increases in AP,
HR, and Rf. Although similar changes were observed in
orexin knockout mice, intensities were smaller and duration
was shorter than those in wild-type mice. Moreover, in an
awake and freely moving condition, telemeter-indwelling
orexin knockout mice showed diminished cardiovascular and
behavioral responses to emotional stress in the resident-
intruder test. We also found that basal AP in orexin knockout
mice was significantly lower in both anesthetized (117  8
mmHg in wild type and 92  3 in knockout) and conscious
(125  6 mmHg in wild type and 109  2 in knockout) condi-
tions. -Adrenergic blockade with prazosin or ganglion blockade
with hexamethonium canceled the difference in basal AP. HR
and cardiac contractile parameters by echocardiography did not
differ between the two strains of mice. These results indicate
lower sympathetic vasoconstrictor tone in knockout mice. The
present study suggests that orexin-containing neurons in the
perifornical area play a role as one of the efferent pathways of
defense response and also operate as a regulator of AP at basal
condition by activating sympathetic outflow.
hypothalamus; stress; respiration; sympathetic nervous sys-
tem; circadian rhythm
OREXIN A and B, also known as hypocretin 1 and 2, are
recently identified neuropeptides that consist of 33 and
28 amino acids, respectively (10, 46). They are proteo-
lytically derived from the same precursor peptide (pre-
pro-orexin) and exert a variety of functions by acting on
orexin receptor type 1 and/or type 2. Orexin-containing
neuron cell bodies are located exclusively in the lateral
and dorsal hypothalamic areas and their axons dif-
fusely innervate almost the entire central nervous sys-
tem (6, 9, 10, 38, 39, 44, 46). This anatomic feature
establishes the bases that orexin contributes to multi-
ple physiological functions, including feeding behavior
(46), energy homeostasis (46, 54), sleep-wake cycle (5),
and regulation of the autonomic and neuroendocrine
systems (9, 22, 44, 54).
Several laboratories have proposed a possible contri-
bution of orexin in cardiovascular regulation by observ-
ing the effects of exogenously administered orexins.
Orexins on intracerebroventricular injection increased
arterial blood pressure (AP), heart rate (HR) (47), renal
sympathetic nerve activity, and plasma catecholamines
(50) in conscious, unrestrained rats. Intrathecal admin-
istration of orexins increased AP and HR (3). Microinjec-
tion of orexin A to the rostral ventrolateral medulla
(RVLM) increased AP and HR in anesthetized rats (7)
and awake rats (36). However, there is no report to date
on whether the same is true for intrinsic orexin.
On the other hand, the perifornical area of the hy-
pothalamus or dorsomedial hypothalamus, a region of
the brain with the highest density of orexin-containing
neurons (9, 10, 44, 46), has been known as the center
for defense response and is sometimes called the de-
fense area (29). Defense response, which is also known
as “fight-or-flight” response, is characterized by a coor-
dinated rise in AP, HR, respiratory frequency (Rf), and
resistance in most vascular beds along with a fall in
resistances in airway and blood vessels in the skeletal
muscles when an animal encounters stressors. A pio-
neer work by Hess (23) showed that electrical stimula-
tion of the posterior hypothalamus in cats elicited
behavioral rage, along with the specific autonomic re-
sponses, that was termed the “defense response.” Al-
though some reports using chemical stimulation with
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excitatory amino acids (e.g., glutamate) had shown no
effect or even a depressor effect (19, 25), later it was
shown that negative results might have been caused by
the stimulation of specific subregions in the posterior
hypothalamus and/or dosage of drugs (14). Actually,
the perifornical area was the most reliable region to
elicit the cardiovascular defense response (29), and an
overdose of excitatory amino acids sometimes inhibited
neuronal activity, an effect known as excitation block
phenomenon (34). Disinhibition with a GABA-A recep-
tor antagonist, bicuculline methiodide, of the perifor-
nical area reliably and dose dependently induced the
defense response (13). Moreover, injection of a GABA
agonist to the defense area inhibited the stress-induced
rise in AP and HR (35).
There is only limited information about neurotrans-
mitter(s) that subserve efferent pathways of the de-
fense responses. Namely, glutamate was proposed to
mediate at least the cardiovascular component of the
defense response (52). However, there is no report on
the molecular basis of the defense response underlying
its multifaceted nature such as concomitant and coor-
dinated changes in cardiovascular, respiratory, and
behavioral parameters. We hypothesized that intrinsic
orexin, synthesized in the perifornical area, may par-
ticipate in the efferent pathway of the defense response
and thought that knockout mice may be useful to test
the hypothesis.
Prepro-orexin knockout mice, which completely lack
both orexin A and orexin B, have been recently estab-
lished (5). They exhibited a phenotype strikingly sim-
ilar to human narcolepsy patients, such as behavioral
arrest resembling cataplectic attack, sleep-onset rapid
eye movement sleep, and diminished awake time in the
dark period. This murine model and the canine model
of narcolepsy that has mutation in the gene for orexin
receptor type-2 (33) suggested the importance of
orexin-orexin receptor type-2 interaction in the patho-
genesis of narcolepsy. In fact, human narcolepsy seems
to be an autoimmune disease, resulting in loss of
orexin-containing neurons in the hypothalamus (53).
On the other hand, there are only a few reports exam-
ining autonomic regulation in human narcolepsy (see
DISCUSSION). Cardiovascular and autonomic phenotypes
in orexin knockout mice have not been examined.
The aim of this study was to test our hypothesis by 1)
identifying hypothalamic subregion(s) in mice suitable
to elicit the defense response and by 2) comparing the
effect of hypothalamic stimulation between orexin null
mutated knockout mice and wild-type mice. Possible
involvement of orexin in the defense response was
further clarified by 3) telemetric measurement of AP
and HR during socioemotional stress of the resident-
intruder test. In the course of the experiments, we
found lower basal AP in orexin knockout mice. There-
fore, an additional aim of this study was to examine
possible involvement of intrinsic orexin in basal car-
diovascular regulation by 4) comparing AP and HR
between mutant and wild-type mice in unanesthetized
freely moving condition with or without pharmacolog-
ical perturbations.
MATERIALS AND METHODS
Animals. Prepro-orexin mutated mice of genetic back-
ground of a mixture of 129/Sv and C57BL/6 were generated
as reported previously (5). They were maintained in het-
erozygotes and crossed to obtain null mutants and wild-type
littermates. Genotype of orexin knockout mice was identified
by PCR on DNA extracted form a tail biopsy in a similar
manner as had been reported except for primer sequences.
We used a 5 primer, GAC CTA TCA GGA CAT AGC GTT
GGC and a 3 primer, TCA CCC CCT TGG GAT AGC CCT
TCC for the mutant allele and a 5 primer, GAC GAC GGC
CTC AGA CTT CTT GGG with the same 3 primer to identify
the wild-type allele. Mice used in this study were 18- to
40-wk-old male orexin null mutated mice and wild-type mice.
Heterozygotes were not used. All mice were housed in plastic
cages in a room maintained at 23–25°C with lights on at 7:00
AM and off at 7:00 PM. Mice had food and water available ad
libitum. All animal procedures conformed to the “Guiding
Principles for the Care and Use of Animals in the Field of
Physiological Sciences” recommended by the Physiological
Society of Japan.
Measurement of cardiorespiratory parameters and electro-
encephalogram in anesthetized mice. Mice were anesthetized
with intraperitoneal injection of urethane (1.1 g/kg); supple-
mentary doses of 0.1–0.5 g/kg were given when required to
maintain a level of anesthesia (average total dose including
all additional doses was 1.22  0.05 g/kg, n  20). We found
this dose was adequate in both orexin knockout mice and
wild-type mice as judged by baseline stability of AP, HR,
respiration, and electroencephalography (EEG) throughout
the experiment. Cardiorespiratory parameters were recorded
as described in our previous reports (31, 42). In brief, AP was
measured by a pressure sensor catheter (SPR-671 microtip
pressure catheter for mouse/rat, Millar, Houston, TX) placed
in the abdominal aorta through an incision of the right
femoral artery. Mean AP (MAP) was calculated by damping
(0.2 Hz low pass) the phasic AP signal. HR was recorded
using an HR counter (AT-601G, Nihon Kohden, Tokyo, Ja-
pan) triggered by the AP pulse. A tracheal cannula (polyeth-
ylene tube, OD  1.20 mm) was inserted through a midline
incision. Respiratory flow signal was obtained through a
Lilley type pneumotachograph (TV-241T and TP-602T, Ni-
hon Kohden) connected to the tracheal tubing. Rf was
counted by a pulse counter (ET-612J, Nihon Kohden). In
experiment 2 (see below), a pair of electrodes to record EEG
was implanted through holes in the skull over the left and
right frontal cortex. Cortical EEG arousal has been impli-
cated as one of the functions of the perifornical lateral hypo-
thalamus (11) and may be a part of defense response. EEG
signals were amplified with band-pass filters of 0.25–100 Hz
(AB-651J, Nihon Kohden). In experiment 1, we did not try to
measure EEG because electrical stimulation in the brain
makes serious noise in EEG.
In both experiments 1 and 2, the animal was placed in the
prone position in a stereotaxic frame (ST-7, Narishige, Tokyo,
Japan) so that bregma and lambda would be horizontal. A
small hole was drilled on the skull for insertion of a metal
electrode or a glass micropipette into the hypothalamus.
After completion of surgery, at least 1 h was allowed to
stabilize all the parameters. Throughout the experiment,
rectal temperature was kept constant at 37.0  1.0°C by a
heating pad connected to a thermo controller (ATB-1100,
Nihon Kohden).
Experiment 1: mapping of hypothalamic areas to induce
defense response. We used 18- to 25-wk-old male wild-type
mice (n  10, body wt 32  3 g). Electrical stimulations were
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made with stainless steel electrodes. Explored brain regions
were the perifornical area and surrounding hypothalamus
(from 1.5 to 2.5 mm caudal to the bregma, from 0.3 to 1.5 mm
lateral to the midline, and from 4.0 to 5.8 mm ventral to the
bregma). An enamel-coated sharp stainless-steel electrode
(0.1 mm of the tip exposed) was inserted into the targeted
region, and the different lead was placed under the skin of
the neck. The electrode was carried in a stereotaxic micro-
manipulator (SM-11, Narishige) and lowered along the track
in steps of 0.3 mm. Three to seven tracks were completed in
each animal, and each track was 0.5 mm apart from the other
tracks. At each point, the brain was stimulated with a train
of rectangular pulses of 0.5-ms duration at 100 Hz for 20 s.
The stimulation currents were 0.3 mA with the negative
electrode. Stimulations were separated by at least 5 min
after all the parameters returned to baseline. We used elec-
trical stimulation in experiment 1 because repeated drug
injection to such a tiny brain as in mice cannot be devoid of
volume effect (34). However, electrical stimulation excites
not only cell bodies but also fibers of passage. Because of such
a disadvantage in electrical stimulation, we used the micro-
injection technique in experiment 2 (see below) to stimulate
only cell bodies but not fibers of passage.
Experiment 2: chemical stimulation of the perifornical
area. Experiments were done in 18- to 25-wk-old male
wild-type mice (n  5, body wt 35  1 g) and prepro-orexin
knockout mice (n  5, 36  2 g). Microinjection of drugs
was made with glass micropipettes (Drummond, 1–5 l)
shaped by a micropipette puller (PE-2, Narishige) and cut
to fit the tip diameter of 20–30 m. The pipettes were
carried in a stereotaxic micromanipulator (SM-11, Narish-
ige) and connected by silicon tubing to a pressure injector
(IM-200J, Narishige). The micropipette was filled with a
GABA-A receptor antagonist, bicuculline methiodide (0,
0.1, 0.3, 1.0 mM), dissolved in artificial cerebrospinal fluid
(ACSF). The tip of the pipette was positioned in the peri-
fornical area, where maximum response was observed in
experiment 1 (2.0 mm caudal to the bregma, 0.65 mm
lateral to the midline, 5.0 mm ventral to the bregma, see
also Fig. 1). While observing the fluid meniscus in the
micropipette through a dissection microscope (OME,
Olympus) equipped with an ocular micrometer, a volume of
20 nl was injected by adjusting pressure and time of
injection. Bicuculline was administered sequentially from
the lowest dose to the highest after recorded parameters
returned to the baseline in each animal.
Fig. 1. Schematic coronal sections of the mouse hypothalamus from 1.5 to 2.5 mm caudal to the bregma showing
effects of electrical stimulation on (left to right) consolidated defense response (Total), mean arterial blood pressure
(MAP), heart rate (HR), and respiratory frequency (Rf). Data were obtained from 10 wild-type (WT) mice. Arc,
arcuate hypothalamic nucleus; DM, dorsomedial hypothalamic nucleus; F, fornix; MT, mammillothalamic tract;
VMH, ventromedial hypothalamic nucleus.
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Experiment 3: measurement of cardiovascular parameters
and activity by radiotelemetry. Experiments were done in 30-
to 40-wk-old male wild-type mice (n  6, body wt 46  3 g)
and prepro-orexin knockout mice (n  6, 52  2 g). A telem-
etry system (Data Sciences International) was used for mea-
suring AP, HR, and locomotor activity. This system consisted
of a radio-frequency transducer (TA11PA-C20) and a receiver
(RLA1020). For implantation of the transducer, mice were
anesthetized with 2–3% isoflurane and given an antibiotic
(cephalosporin, 50 mg/kg sc). A midline incision was made on
the neck, and the left common carotid artery was isolated. A
small cut was made in the vessel wall, and the catheter-
transducer was implanted in the thoracic aorta through the
hole. The sensor was tunneled subcutaneously and fixed to
the abdominal wall. Finally, the incision was closed with
sutures. Care was taken to maintain body temperature dur-
ing and after the surgery. Mice were returned to their home
cages and housed individually during the recovery and re-
cording period. All the mice were allowed at least 5 days of
recovery from surgery until circadian rhythm was evident in
both AP and HR (4).
After the recovery period, AP, HR, and activity were re-
corded for successive 2–3 days using Dataquest LabPRO
software (Data Sciences) in unrestrained, freely moving, and
unanesthetized conditions.
Two types of stressor were applied in the afternoon on the
following day after the basal measurement was completed.
The first one was a socioemotional stressor in the resident-
intruder test (31). A group-housed, age-matched wild-type
mouse (intruder) was placed in the cage for 5 min. When AP,
HR, and activity returned to the baseline, a second trial of
the resident-intruder test was performed, but the telemeter-
indwelling animal served as the intruder this time. Cardio-
vascular and behavioral responses in the first and second
trials in the resident-intruder test are called “resident re-
sponse” and “intruder response,” respectively, in this study.
The second stressor was noxious stimuli. Vascular clamps of
two strengths (60 and 125 g, Fine Science Tools, nos. 18055–
01 and -04) were attached to the tail for 10 s.
Finally, on the following day in the light phase, urethane
(1.1 g/kg) was intraperitoneally administered to see whether
the difference in AP observed in experiment 2 (see RESULTS)
could be reproduced and to confirm that attenuation of de-
fense response observed in experiment 2 did not result from
generally increased susceptibility of the knockout mice to
anesthesia.
Experiment 4: measurement of cardiovascular parameters
with indwelling catheter and pharmacological interventions.
Experiments were done in 18- to 25-wk-old male wild-type
mice (n  21, body wt 33  1 g) and prepro-orexin knockout
mice (n  14, 33  1 g). For simultaneous AP measurement
and intravascular drug delivery, we used an indwelling cath-
eter to minimize surgical damage because telemetric AP
measurement needs additional operation for this purpose.
Under isoflurane anesthesia, polyethylene tubing was in-
serted into the femoral artery for both AP measurement and
drug delivery as reported (41). On the following day during
the light phase, AP and HR were measured continuously for
2 h under conscious and unrestrained conditions in a quiet
environment after at least 1 h of acclimatization. Thereafter,
the animals were divided into three groups. The first group
was given intra-arterially a ganglion blocker, hexametho-
nium (20 mg/kg, n  13 in wild-type mice and n  6 in
knockout mice), to examine possible contribution of the au-
tonomic nervous system in the difference in basal AP be-
tween knockout and wild-type mice. The second group was
given an angiotensin-converting enzyme inhibitor, captopril
(30 mg/kg, n  3 in both wild-type and knockout mice), to
examine possible interaction of ANG II and orexin, since
orexin has been shown to stimulate drinking behavior as
potently as ANG II (30). The third group (n  5 in both
wild-type and knockout mice) was sequentially given two
drugs: a vasopressin V1a receptor antagonist, [-mercapto-,-
cyclopentamethylenepropionyl1, O-me-Tyr2, Arg8]vasopressin
(10 g/kg), and an -adrenergic blocker, prazosin (1 mg/kg).
Effect of the V1 receptor antagonist was tested because
orexin-containing neurons innervate neurons in the paraven-
tricular nucleus containing vasopressin (51). Resulting AP
and HR were calculated as the peak value within 1 h after
the administration.
Experiment 5: measurement of echocardiography. Experi-
ments were done in 14- to 18-wk-old male wild-type mice (n
6) and prepro-orexin knockout mice (n  6). Anesthetized
(pentobarbital sodium, 50 mg/kg ip) animals were observed
with a 2D-guided M-mode echocardiographic system
equipped with a 12-MHz imaging transducer (Sonos 4500;
Agilent Technologies, Osaka, Japan). Left ventricular (LV)
diastolic diameter (LVDD) and LV systolic diameter (LVSD)
were measured. LV end-diastolic volume (LVEDV) and LV
end-systolic volume (LVESV) were calculated by the cubed
method as (LVDD)3/3 and (LVSD)3/3, respectively. We
also calculated percent fractional shortening [%FS  100 
(LVDD 	 LVSD)/LVDD], stroke volume (SV  LVEDV 	
LVESV), and ejection fraction (%EF  100  SV/LVEDV).
Three beats were averaged for each measurement.
Data analysis and statistical procedure. All the signals
were fed into a personal computer (Macintosh, Apple Com-
puter) after analog-to-digital conversion (model 1401, CED,
UK or MacLab, AD Instrument, Australia) together with
event signals.
In experiment 1, the baseline value was the mean value
before stimulation for 20–30 s, and the peak value was
calculated as a mean value for 5–10 s around the maximum
response.
In experiment 2, data were averaged for every 1 min. The
baseline value was the mean value during 5 min before
injection of bicuculline. Recovery time was defined as the
time from injection until MAP, HR, or Rf returned to the
value 5% above the baseline, because spontaneous fluctua-
tion of these parameters during control period was within
5% range of the mean value. We also calculated the area
under the curve (AUC) above the baseline value during
periods of 10, 15, 20, and 30 min from the injection for 0, 0.1,
0.3, and 1.0 mM of bicuculline, respectively. The length of the
periods was determined from the result of recovery time in
wild-type mice (see Table 1). To estimate the cortical arousal
level, we calculated the power spectra of EEG using fast
Fourier transformation (FFT; length of sections 5 s, FFT
number 512). Arousal level was determined as relative
-band (13–50 Hz) power to the total band powers. For
relative -band power, recovery was defined as the time point
when the value returned to a value 20% above the baseline,
since spontaneous fluctuation of this parameter during con-
trol period was within 20% range of the mean value.
For circadian measurement in experiment 3, AP, HR, and
activity counting were averaged for every 30 min. Values in
each animal were analyzed by the cosinor method (40) to
calculate midline estimating statistic of rhythm (MESOR)
and amplitude. The mean light and dark phase values were
also calculated. In the resident-intruder test, AP, HR, and
activity counting were averaged for every 1 min. AUC was
calculated for 5 min when resident and intruder were in the
same cage. In the tail-clip test, resulting AP and HR were
calculated as the peak value within 30 s after the start of
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clipping. In urethane treatment, pretreatment value was
calculated as the mean during the 0.5 h immediately before
injection. Posttreatment value was the average during the
period from 1 to 6 h after injection, since experiment 2 was
usually completed within 6 h.
All data are expressed as means  SE. Effects of microin-
jection of bicuculline on cardiovascular, respiratory, and
arousal responses were assessed by ANOVA with repeated
measures design. Post hoc comparisons of Student-Newman-
Keuls procedure or unpaired t-test were used to compare
between genotypes. A value of P 
 0.05 was considered
significant.
Histological verification of stimulation sites. At the end of
the experiment, the injection site was marked by injecting 20
nl of a 2% Evans blue solution in experiment 2. In experiment
1, the same Evans blue solution was injected to the site
where electrical stimulation was finally performed. The ani-
mal was deeply anesthetized with additional urethane and
transcardially perfused with 20 ml of heparin-added saline
followed by 20 ml of 4% formalin. The brains were removed
and stored in the formalin solution for at least 2 days before
sectioning. Coronal or sagittal sections of 50-m thickness
were cut serially with a micro slicer (DTK-1000, Dosaka EM,
Kyoto, Japan), mounted on poly-L-lysine-coated slides, and
stained with 1% neutral red or 0.5% cresyl violet. The loca-
tions of the injection sites were determined according to the
atlas of Paxinos and Franklin (43).
RESULTS
Experiment 1: mapping of hypothalamic areas to
induce defense response. To examine whether hypotha-
lamic stimulation induces defense response in mice as
in other experimental animals, the effect of electrical
stimulation on cardiorespiratory parameters was sys-
tematically explored. Ninety-three histologically veri-
fied sites within the targeted area were examined in 10
mice. Average MAP, HR, and Rf before stimulation
were 115  4 mmHg, 570  15 beats/min, and 194 
5/min, respectively. Electrical stimulation in most sites
resulted in increases in MAP, HR, and Rf except for 11
sites to which stimulation resulted in decreases in HR.
Response magnitude of each parameter was ranked
into three levels and is shown in Fig. 1. Stimulation at
caudal hypothalamic sites induced a pressor response.
The most effective sites were located in the dorsolat-
eral region in the caudal hypothalamus, where electri-
cal stimulation resulted in an increase in MAP by 50
mmHg (Fig. 1). In regard to HR, effective sites were
roughly overlapped with but extended more widely
compared with the effective sites for MAP. Electrical
stimulation at most of the explored sites in the caudal
hypothalamus produced an increase in HR by 20
beats/min. An increase in Rf was elicited in the middle
to lateral part of the caudal hypothalamus, in which
responses in Rf were 300/min.
To map the most effective sites for eliciting defense
response, in other words coordinated increases in
MAP, HR, and Rf, the rank of response magnitude in
each parameter was scored as 2, 1, or 0 points from the
highest to the lowest in this order, and summation of
scores was calculated for each stimulating site (Fig. 1,
left). The total score was highest at three sites in the
dorsal part of the perifornical area. The most effective
sites were located at 0.65 mm lateral to the midline,
4.7–5.0 mm ventral to the bregma in the plane of 2.0
mm caudal to the bregma, and 1.0 mm lateral, 4.7 mm
ventral in the plane of 2.5 mm caudal to the bregma.
These results clearly show that defense response can
be elicited by electrical stimulation of dorsal hypothal-
amus, especially the dorsal part of the perifornical area
in mice. From these results, we decided to stimulate a
point 2.0 mm caudal to the bregma, 0.65 mm lateral to
the midline, and 5.0 mm ventral to the bregma in the
following experiment.
Experiment 2: chemical stimulation of the periforni-
cal area in orexin knockout mice. To test our hypothesis
that orexin may contribute to expression of the defense
response, we compared the effects of chemical stimu-
lation with bicuculline to the perifornix on cardiorespi-
ratory and EEG parameters between orexin null mu-
tated knockout mice and wild-type littermates. Before
stimulation, the average values of MAP, HR, Rf, and
relative -power in five wild-type mice were 117  8
mmHg, 558 12 beats/min, 178 7/min, and 14 2%,
respectively. In wild-type mice, microinjection of 0.1–1
mM of bicuculline to the perifornical area elicited dose-
dependent increases in MAP, HR, Rf, and relative
-power (Fig. 2), but ACSF (vehicle) did not cause any
significant changes. By 0.1, 0.3, and 1.0 mM of bicucul-
line, peak increases in MAP (11 2%, 13 1, and 28
2%), HR (13  3, 17  2, and 19  4%), Rf (54  6,
103  7, and 167  15%), and relative -power (111 
22, 122  39, and 121  17%) were all statistically
significant. These changes began within 15 s from
injection of bicuculline and returned to baseline within
10–30 min depending on the dosage (Table 1).
In orexin knockout mice, basal values of MAP, HR,
Rf, and relative -power were 92  3 mmHg, 562  22
beats/min, 218  11/min, and 13  3%, respectively.
MAP was significantly (P 
 0.05) lower and Rf was
significantly higher than that in wild-type mice (Fig.
2). Basal HR and relative -power were not signifi-
cantly different between the genotypes. At a glance,
microinjection of bicuculline to the perifornical area in
the mutant mice appeared to result in similar cardio-
Table 1. Duration of responses by bicuculline
Parameter
Dose of
Bicuculline,
mM in 20 nl
Wild-Type
Mice
Knockout
Mice
Blood pressure 0.1 10.82.6 2.61.7*
0.3 15.82.9 5.01.6*
1 26.02.7 14.02.2*
Heart rate 0.1 12.41.6 1.81.1*
0.3 22.82.4 9.02.8*
1 31.82.3 25.25.5
Respiratory frequency 0.1 12.41.6 1.61.0*
0.3 19.22.8 9.41.4*
1 21.22.6 19.63.7
EEG -band power 0.1 11.01.0 2.20.9*
0.3 18.82.2 8.62.6*
1 28.24.7 11.01.4*
Values are means  SE of response duration in min. *P 
 0.05 vs.
wild-type mice (repeated-measure ANOVA followed by post hoc test
of Student-Newman-Keuls).
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respiratory responses to those in wild-type mice (Fig.
2). In detailed analysis, however, there was a signifi-
cant quantitative difference between knockout mice
and wild-type mice. Whereas 0.1 mM of bicuculline was
effective to elicit significant changes in MAP, HR, and
Rf in wild-type mice, the same dose of bicuculline did
not cause any significant changes in the knockout mice
(Fig. 2, A–D, left), except for a small and shortlasting
increase in HR. At the dose of 0.3 mM, cardiorespira-
tory responses in the knockout mice were shorter last-
ing than those in wild-type mice (Fig. 2, A–D, middle,
and Table 1). At the dose of 1.0 mM, responses in AP
and EEG were still shorter lasting although recovery
time of HR and Rf responses was not statistically
different from the wild-type mice (Fig. 2, A–D, right,
and Table 1). Consequently, response magnitudes as
calculated by AUC were significantly smaller in knock-
out mice for all the parameters (Fig. 2E) at least for 0.1
and 0.3 mM of bicuculline.
By histological examination, there was no difference
in the dye distribution between wild-type mice and
orexin knockout mice, and all the injections were suc-
cessfully made in dorsal part of the perifornical area
(Fig. 3).
Experiment 3: measurement of cardiovascular pa-
rameters and activity by radiotelemetry. Attenuation of
defense response in orexin knockout mice was further
confirmed by radiotelemetric measurement of behav-
ioral and cardiovascular parameters in unanesthetized
freely moving mice with a natural stressor (Fig. 4). At
the baseline before stress, low AP and similar HR in
orexin knockout mice were observed as was the case in
anesthetized condition. When the test animal was con-
fronted with an intruder, increases in AP, HR, and
activity were significantly smaller in orexin knockout
mice than in wild-type mice (Fig. 4A). The same was
true when the test animal intruded into a resident’s
home cage (Fig. 4B). On the other hand, noxious stim-
uli of the tail pinch elicited similar increases in AP and
HR in both genotypes, irrespective of stimulus inten-
sity (Fig. 5).
We next examined circadian rhythm of AP, HR, and
activity in the orexin knockout mice, because deficiency
of orexin has been shown to induce disturbance in
sleep-awake cycle and thus may induce abnormality in
circadian rhythm of cardiovascular parameters. Activ-
ity during dark phase but not during light phase was
significantly lower in orexin knockout mice and thus
amplitude of 24-h fluctuation in activity was signifi-
cantly lower in the mutant mice (Fig. 6, Table 2).
Contrary to our expectation, however, circadian fluctu-
ation of AP and HR was similar between knockout and
wild-type mice except that AP in knockout mice was
consistently lower during both dark phase and light
phase. Although amplitude of AP in orexin knockout
mice tended to be smaller, the difference did not reach
statistical significance (P  0.34).
To exclude the possibility that basal hypotension in
orexin knockout mice in experiment 2 was due to a
difference in sensitivity to anesthetic, we next exam-
ined the effect of urethane administration on AP and
HR in radiotelemeter-indwelling mice. As expected,
urethane lowered AP in a similar manner in mutant
(before urethane, 108  3 mmHg and after, 83  5
mmHg, 	23.5  3.5%) and wild-type mice (before ure-
thane, 127  6 mmHg and after, 102  7 mmHg,
	19.7 3.6%). HR was not different between knockout
Fig. 2. Effects of microinjection of bicuculline methiodide to the perifornical area in urethane-anesthetized WT
mice and orexin knockout mice (KO) on arterial blood pressure (A), HR (B), Rf (C), and relative -band power of
EEG (D), an indicator of arousal. Arrowheads indicate timing of microinjection of bicuculline (20 nl). E: changes in
above parameters expressed as area under the curve (AUC). Data are presented as means  SE of 5 WT mice and
5 KO mice. *P 
 0.05, **P 
 0.01 vs. WT mice.
Fig. 3. Photomicrographs of coronal (A,
at the level of 2 mm caudal to the
bregma) and sagittal (B, at the level of
0.65 mm lateral to the midline) sections
through the hypothalamus prepared af-
ter the experiment. Injection site of bicu-
culline was marked with Evans blue.
Each section was stained with 1% neu-
tral red. Ant, anterior; Post, posterior.
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mice and wild-type mice either before or after injection
of urethane (data not shown).
Experiment 4: measurement of cardiovascular pa-
rameters with indwelling catheter and pharmacologi-
cal interventions. Lower basal AP in orexin knockout
mice was again confirmed in this experiment (Fig. 7A).
Basal HR of both genotypes (Fig. 7B) was higher than
that in experiment 3 where cardiovascular parameters
were measured with radiotelemeter (Table 2). Never-
theless, there was no difference in HR between the
knockout mice and wild-type mice as was the case in
experiment 3.
To examine why basal AP was lower in orexin knock-
out mice, possible abnormalities of the renin-angioten-
sin system, vasoconstriction through vasopressin V1
receptor, or autonomic nervous system were evaluated
using captopril, V1 antagonist, hexamethonium, and
prazosin. Administration of captopril lowered AP in
both mutant (	12.0  1.7%, n  3) and wild-type mice
(	11.9  2.7%, n  3) in a similar manner (P  0.05).
Resultant AP was still lower in knockout mice than in
wild-type mice, although the difference did not reach
statistical significance presumably because of small
numbers of the animals. V1 antagonist did not affect
AP in either mutant (	4.6  2.5%, n  5) or wild-type
mice (	2.6  1.1%, n  5). Thus resultant AP was still
significantly lower in knockout mice (Fig. 7A). On the
other hand, hexamethonium lowered AP more in wild-
type (	32.1  2.1%, n  13) than in mutant mice
(	23.4  2.6%, n  6; P 
 0.05). Resulting AP was not
different between the two. In a similar manner, prazo-
sin lowered AP greater in wild-type (	62.2 3.1%, n
5) than in mutant mice (	51.2  2.5%, n  5; P 

0.05). Difference in AP was canceled after the treat-
ment with prazosin (Fig. 7A). There was no difference
in HR between the two strains with any drugs used in
the current experiment (Fig. 7B).
Experiment 5: measurement of echocardiography. To
examine the possibility that cardiac abnormality con-
tributed to the lower AP in orexin knockout mice, we
measured echocardiography in another set of the ani-
mals. Stroke volume and other basal contractile pa-
rameters were not significantly different between the
two groups (Table 3).
DISCUSSION
We demonstrated here that electrical stimulation
and disinhibition of GABAergic input to the periforni-
cal area elicited the cardiovascular and respiratory
defense responses and increased arousal level in ure-
thane-anesthetized mice in a similar manner as in cats
(1), rabbits (49), and rats (13, 57). A recent report that
spontaneous activity of identified orexin-containing
neuron in slice preparation was inhibited by the
GABA-A receptor agonist muscimol supports the rele-
Fig. 4. Cardiovascular and behavioral responses during the resident-intruder test in radiotelemeter-indwelled
freely moving WT mice and orexin KO mice. A: resident response when the test animal was confronted with an
intruder. B: intruder response when the test animal intruded into a resident’s home cage. The presence of an
intruder (or resident) is indicated by the horizontal solid bar. Right side panels are the changes in blood pressure,
HR, and activity expressed as AUC during 5 min when an intruder or resident was present in the same cage. Data
are presented as means  SE of 6 WT mice and 6 KO mice. *P 
 0.05, **P 
 0.01 vs. WT mice.
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vance of our experimental setup (16, 32). The increase
in AP during electrical stimulation of the hypothalamic
regions seemed to be due to increasing resistance,
because HR did not change much (20 beats/min, Fig. 1).
It is likely that baroreflex was suppressing major in-
creases in HR in these conditions. We did not examine
the blood flow redistribution to skeletal muscle from
visceral vascular beds, another characteristic of the
defense response. However, mice made movement of
limbs that resembled running by microinjections of
bicuculline and electrical stimulations (data not
shown), indicative of defense response. Cardiovascular,
respiratory, and arousal components of the defense
response seem to be mediated, at least in part, by
orexin-containing neurons. Moreover, intrinsic orexin
participates in blood pressure maintenance at basal
conditions probably through activation of the sympa-
thetic vasoconstrictor outflow. To the best of our knowl-
edge, this is the first report demonstrating that endog-
enous orexins play a role in cardiovascular and respi-
ratory regulations in the central nervous system.
Present results confirmed the proposal of possible
contribution of orexin in cardiovascular regulation (3,
7, 15, 26, 36, 47, 50) and in stress-induced behavior (27,
55). In other words, our present results using knockout
mice were generally in accordance with the earlier
reports using exogenous application of orexin and de-
termination of orexin content in the brain. Moreover,
we successfully linked cardiovascular and stress regu-
latory roles of orexin by showing attenuation of defense
response in orexin knockout mice in both anesthetized
and freely moving conditions.
We demonstrated here diminished defense response
in orexin knockout mice, but the response was not
completely abolished. Preserved responses, namely
short-lasting cardiorespiratory excitation at low doses
of bicuculline and even similar responses in HR and Rf
at high dose of bicuculline (Fig. 2), should be mediated
by other transmitter(s)/modulator(s) than orexin. Ex-
istence of other factors than orexin is further suggested
by incomplete disappearance of cardiovascular and be-
havioral responses in resident-intruder test (Fig. 4).
Fig. 5. Cardiovascular responses during noxious stimuli. Peak
changes in blood pressure (A) and HR (B) within 30 s after the start
of stimulation are summarized for WT mice (open bar, n  6) and
orexin KO mice (solid bar, n  6). Mild and strong stimulations were
applied by attaching two strengths (60 and 125 g, respectively) of
vascular clamps to the tail for 10 s.
Fig. 6. Circadian patterns of blood pressure, HR, and activity. Sym-
bols of filled circles and cross are average values from orexin KO mice
(n  6) and WT mice (n  6), respectively. Bars indicate 1 SE.
Filled bars along the top horizontal axis indicate the dark phase of
the 12:12-h light-dark cycle. bpm, Beats/min.
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Perhaps glutamate may be one of such transmitters,
since bilateral microinjection into the RVLM of an
ionotropic excitatory amino acid receptor antagonist
kynurenic acid attenuated an increases in AP and
renal sympathetic nerve activity evoked by air jet
stress (37) or by direct hypothalamic stimulation (52).
Orexin was able to increase pre- and postsynaptic
activity of the glutamate-releasing neurons (54). Thus
orexin may act as a modulator of glutamatergic input
into the RVLM. A toxin-induced orexin-neuron specific
degenerative animal model (21) may help to study
other factors, especially cotransmitters contained in
the orexin neuron, involved in defense response. On
the other hand, above-cited reports dealt with only the
cardiovascular components of the defense response.
There is little information about neurotransmitter(s)
that convey respiratory or behavioral component of the
defense response. In this respect, this is the first report
suggesting a possible neurotransmitter/modulator that
contributes to the simultaneous and coordinated
changes in cardiovascular, respiratory, EEG, and be-
havioral components of the defense response.
The present study did not clarify the site at which
orexin acted in the central nervous system and the
mechanisms of cardiovascular and respiratory re-
sponses induced by disinhibition of GABAergic neuro-
transmission in the perifornical area. However, previ-
ous studies enabled us to suppose key sites where
orexin acted as a mediator of defense response. The
most apparent site seems to be the RVLM, since inhi-
bition of RVLM or subjacent ventral surface of the
medulla (glycine-sensitive area) attenuated sympa-
thetic and defense responses evoked by stimulation to
the lateral hypothalamic area (12, 24, 52). A double-
virus transneuronal labeling technique revealed that
not only perifornical neurons but also RVLM neurons
provided a dual input to the sympathetic outflow sys-
tems that regulate cardiac and adrenal medullary
functions, indicating these neurons were the “central
command neurons” of defense response (28). Actually,
orexin immunoreactive fibers were seen in the RVLM
(44), and exogenous applied orexin into the RVLM
elicited AP and sympathetic excitation (7, 36). Present
results with hexamethonium and prazosin also support
the view since RVLM is the major source of sympa-
thetic outflow (8). Nevertheless, we cannot exclude the
possible involvement of sites other than RVLM, such as
periaqueductal gray, nucleus tractus solitarius, or in-
termediolateral cell column of the spinal cord (2, 26), as
active sites of orexin in the defense response. This
subject needs further experimentation.
In clear contrast to attenuated cardiovascular re-
sponses to socioemotional stress by resident-intruder
Table 2. Circadian statistics and values
for light and dark phases
Parameter Wild-Type Mice Knockout Mice
Blood pressure, mmHg
MESOR 1256 1092*
Amplitude 92 61
Acrophase (h:min) 0:030:56 1:200:46
Light phase mean 1226 1072*
Dark phase mean 1286 1132*
Heart rate, min	1
MESOR 52941 56522
Amplitude 358 344
Acrophase (h:min) 0:480:42 2:500:49
Light phase mean 52728 55323
Dark phase mean 55438 57521
Activity, counts/30 min
MESOR 13524 8417
Amplitude 7920 254*
Acrophase (h:min) 2:090:43 2:480:13
Light phase mean 9817 7817
Dark phase mean 16226 9117*
Values are means  SE of 6 mice in each genotype. MESOR,
midline estimating statistic of rhythm. *P 
 0.05 vs. wild-type mice
(t-test).
Fig. 7. Cardiovascular effects of intra-arterial injection of hexame-
thonium (hex), captopril, vasopressin V1 receptor antagonist (anti-
AVP), and prazosin. MAP (A) and HR (B) were measured through
indwelling catheter during pre- and postinjection periods in orexin
null mutated mice (filled bars) and in WT mice (open bars). Numbers
below horizontal axis indicate numbers of animals used in the
measurement.
Table 3. Echocardiography parameters
Parameter Wild-Type Mice Knockout Mice
Body weight, g 30.30.7 29.01.1
LV diastolic diameter, mm 3.540.06 3.450.13
LV systolic diameter, mm 1.990.06 1.990.08
LV end-diastolic volume, l 46.62.2 43.74.9
LV end-systolic volume, l 8.290.69 8.421.14
Stroke volume, l 38.31.7 35.33.9
Fractional shortening, % 43.91.1 42.40.8
Ejection fraction, % 82.31.0 80.80.8
Values are means  SE of 6 mice in each genotype. No parameters
were significantly different between orexin-knockout and wild-type
mice. LV, left ventricular.
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test, AP and HR responses to noxious stimuli by tail
pinch were not different between orexin knockout mice
and wild-type mice (Fig. 5). This may be because stim-
ulus duration was shorter in tail pinch (10 s) than in
resident-intruder test (5 min). Another explanation
may be that cardiovascular responses to noxious stim-
uli by tail pinch do not always require supraspinal
structures (48) and hence the responses are indepen-
dent from hypothalamic orexin. On the other hand,
intrathecal administration of orexin induced analgesia
in rats (56). Analgesia but not exaggerated pain re-
sponse may be advantageous to defense response. Thus
orexin may also participate in stress-induced analge-
sia. Although this hypothesis should be clarified in
future experiments, we can say, at present, that the
orexin system may be activated by some but not all
kinds of stressors. We cannot exclude the possibility
that absence of orexin resulted in some deficit in sen-
sory system for socioemotional stress but not for nox-
ious stressor. Nevertheless, results from urethane-
anesthetized mice with direct hypothalamic stimula-
tion point to a probable deficit in effecter pathway.
Circadian rhythm of AP and HR, calculated as phase
and amplitude, was not significantly different between
orexin knockout mice and wild-type mice although
activity during dark phase was less in the mutant mice
(Fig. 6, Table 2). The latter observation was consistent
with previous studies showing reduced awake time and
increased sleep time during dark phase in orexin
knockout mice (5) and reduced activity during dark
phase in orexin neuron-ablated mice (21). It is not clear
from the present experiment why amplitudes of circa-
dian fluctuations of AP and HR were not different
between the two strains while that of activity was
smaller in orexin knockout mice. Activity may not be
the sole determinant of AP and HR. Whatever may be
the reason, an important point is that AP in orexin
knockout mice was smaller than wild-type mice even
during the light phase when both animals were at rest
and activities were not different between the two. The
difference in AP was also independent of HR or cardiac
contractility (Table 3). The cause of the difference in
AP seemed to be attenuated sympathetic outflow that
regulates peripheral vascular resistance in orexin
knockout mice (Fig. 7). Basal cardiac sympathetic
nerve activity seems not influenced by the absence of
orexin. Contribution of the renin-angiotensin system
and vasopressin V1 receptor seemed minimal, al-
though small numbers of the animals prevented us
from making conclusive remarks about the former. Our
conclusion is in line with sympathetic excitation by
exogenously administered orexin (3, 15, 50) and ex-
tended possible contribution of orexin to basal deter-
mination of AP through tonic excitation of sympathetic
nervous system.
Perspectives
The difference in AP between two genotypes was
maintained after urethane anesthesia and attenuated
defense response was observed in both awake and
anesthetized conditions. This suggests that the differ-
ence in basal AP cannot be explained by possible at-
tenuation of defense response in orexin knockout mice
because defense response is not always activated in
daily life or under anesthesia. It is possible that there
may be two subgroups of orexin-containing neurons:
one group contributes to determination of basal AP and
another participates in defense response, since orexin-
containing neurons widely distribute in lateral hypo-
thalamus and dorsomedial hypothalamus (39) and sub-
populations of orexin neurons have been proposed in
respect to responses to psychotic drugs (18). However,
orexin neurons may be activated only by arousal with-
out any particular stress (17). Therefore, it is also
possible that the same orexin system contributes to
both basal AP determination by mild activation and to
defense response when further activated by stress. We
do not have the answer at present on this issue.
There are only a few reports describing autonomic
regulation in narcolepsy patients. Sachs and Kaijser
(45) reported that never-medicated narcoleptic pa-
tients showed attenuated autonomic reflexes (changes
in AP and HR) in handgrip test and Valsalva’s maneu-
ver, but not in face immersion test or orthostatic stand-
ing. Because some but not all reflexes had been dis-
turbed, they proposed intact peripheral nerves and a
localization of the defect to the central nervous system.
Our findings of attenuated defense response and pre-
served pain-induced response in orexin-deficient mice
are in accordance with their findings in human narco-
lepsy. Basal AP in narcolepsy patients is rather con-
troversial. The same authors reported normal AP and
HR at rest before the autonomic testing (45). However,
Guilleminault (20) reported that withdrawal of medi-
cation with amphetamine for 4 wk significantly de-
creased AP in narcoleptic patients, indicating low AP,
otherwise taking a central stimulant (20). To the best
of our knowledge, 24-h AP and HR have not been
reported in narcoleptic patients. We feel that system-
atic reinvestigation about autonomic regulation in nar-
coleptic patients is needed, since these reports cited
here appeared before 1999 when deficiency of orexin
had been revealed as the cause of narcolepsy.
In summary, we found that defense response could
be elicited in mice as in the other experimental animals
by stimulation to the perifornical region of the poste-
rior hypothalamus. Anesthetized prepro-orexin knock-
out mice showed lower blood pressure and faster respi-
ratory frequency than those in the wild-type mice and
attenuated defense response evoked by microinjection
of bicuculline. Attenuated defense response and hypo-
tension was also reproduced in unanesthetized freely
behaving mutant mice. The hypotension observed
might be due to an attenuated sympathetic outflow.
The present study suggests that orexin-containing
neurons in the perifornical area play a role for one of
the efferent pathways of defense response. Moreover,
intrinsic orexin contributes to the maintenance of
basal blood pressure.
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